ADC Therapeutics S.A. (ADCT)
NYSE: ADCT
· Real-Time Price · USD
4.25
0.14 (3.53%)
At close: Oct 15, 2025, 3:59 PM
4.14
-2.65%
After-hours: Oct 15, 2025, 06:59 PM EDT
ADC Therapeutics S.A. Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 70.84M | 69.56M | 209.91M | 33.92M |
Cost of Revenue | 5.95M | 2.53M | 4.58M | 1.39M |
Gross Profit | 64.89M | 67.03M | 205.33M | 32.52M |
Operating Income | -130.65M | -165.99M | -123.63M | -261.72M |
Interest Income | 12.27M | 10.54M | 2.57M | 66K |
Pretax Income | -156.14M | -195.42M | -154.66M | -251.5M |
Net Income | -157.85M | -240.05M | -155.8M | -230.03M |
Selling & General & Admin | 85.91M | 105.89M | 143.49M | 136.24M |
Research & Development | 109.63M | 127.13M | 187.9M | 158M |
Other Expenses | -3.28M | n/a | n/a | n/a |
Operating Expenses | 192.27M | 233.01M | 328.96M | 294.24M |
Interest Expense | 50.21M | 46.33M | 36.73M | 18.34M |
Selling & Marketing Expenses | 21.44M | 57.46M | 35.75M | 64.78M |
Cost & Expenses | 201.49M | 235.54M | 333.54M | 295.64M |
Income Tax Expense | 166K | 39.11M | 1.14M | -21.48M |
Shares Outstanding (Basic) | 97.16M | 81.71M | 78.15M | 76.75M |
Shares Outstanding (Diluted) | 97.16M | 81.71M | 78.15M | 76.75M |
EPS (Basic) | -1.62 | -2.94 | -1.99 | -3 |
EPS (Diluted) | -1.62 | -2.94 | -1.99 | -3 |
EBITDA | -103.71M | -146.76M | -108.06M | -223.72M |
EBIT | -106.99M | -150.03M | -110.09M | -233.16M |
Depreciation & Amortization | 3.28M | 3.27M | 2.39M | 2.63M |
Source: Financial Modeling Prep. Financial Sources.